Cart
sales@molnova.com
Vatalanib hydrochloride
CAS No. 212141-52-1
Vatalanib hydrochloride( —— )
Catalog No. M37594 CAS No. 212141-52-1
Vatalanib hydrochloride (PTK787; ZK-222584; CGP-797870) functions as an inhibitor of VEGFR2/KDR, displaying an IC50 value of 37 nM .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 335 | In Stock |
|
| 10MG | 502 | In Stock |
|
| 25MG | 809 | In Stock |
|
| 50MG | 1088 | In Stock |
|
| 100MG | 1469 | In Stock |
|
| 200MG | 1981 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameVatalanib hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionVatalanib hydrochloride (PTK787; ZK-222584; CGP-797870) functions as an inhibitor of VEGFR2/KDR, displaying an IC50 value of 37 nM .
-
DescriptionVatalanib (PTK787; ZK-222584; CGP-797870) hydrochloride is an inhibitor of VEGFR2/KDR with an IC50 of 37 nM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number212141-52-1
-
Formula Weight383.27
-
Molecular FormulaC20H16Cl2N4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN(C=1C2=C(C(CC=3C=CN=CC3)=NN1)C=CC=C2)C4=CC=C(Cl)C=C4.Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wood JM, et al. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. Cancer Res. 2000;60(8):2178-2189.?
molnova catalog
related products
-
Apigenin 7-O-(2G-rha...
Apigenin-7-O-(2G-rhamnosyl)gentiobioside is a flavone glycosides from Lonicera gracilipes var. glandulosa.
-
[Sar1, Ile8]-Angiote...
[Sar1, Ile8]-Angiotensin II (TFA) is a peptide that has multiple effects on vascular smooth muscle, including contraction of normal arteries and hypertrophy or hyperplasia of cultured cells or diseased vessels.
-
AKOS037652256
AKOS037652256 can be used as a TRPML modulator for the treatment of diseases associated with TRPML activity such as lysosomal accumulation disorders, muscular dystrophy, common age-related neurodegenerative diseases, oxidative stress or reactive oxygen species (ROS)-related diseases and ageing.
